A novel drug–phospholipid complex loaded micelle for baohuoside I enhanced oral absorption: in vivo and in vivo evaluations

References

• China Pharmacopoeia Committee, Pharmacopoeia of the people’s Republic of China. (2010). Chemical Industry Press, Beijing, China. Vol 1. 306–307.
   Google Scholar
• Ma H, He X, Yang Y, Li M, Hao D, Jia Z. (2011). The genus Epimedium: an ethnopharmacological and phytochemical review. J Ethnopharmacol, 134:519–541.
   PubMed Web of Science ®Google Scholar
• Liu J, Lou YJ. (2004). Determination of icariin and metabolites in rat serum by capillary zone electrophoresis: rat pharmacokinetic studies after administration of icariin. J Pharm Biomed Anal, 36:365–370.
   PubMed Web of Science ®Google Scholar
• Lee KS, Lee HJ, Ahn KS, Kim SH, Nam D, Kim DK et al. (2009). Cyclooxygenase-2/prostaglandin E2 pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells. Cancer Lett, 280:93–100.
   PubMed Web of Science ®Google Scholar
• Kim SH, Ahn KS, Jeong SJ, Kwon TR, Jung JH, Yun SM et al. (2011). Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells. Eur J Pharmacol, 654:10–16.
   PubMed Web of Science ®Google Scholar
• Zhai YK, Ge BF, Chen KM, Ma HP, Ming LG, Li ZF. (2010). Comparative study on the osteogenic differentiation of rat bone marrow stromal cells effected by icariin and icariside II. Zhong Yao Cai, 33:1896–1900.
   PubMedGoogle Scholar
• Jeong EJ, Liu X, Jia X et al. Coupling of conjugating enzymes and efflux transporters impact on bioavailability and drug interactions. (2005). Curr. Drug. Metab, 6:455–468.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhao YH, Jia XB, Hu M. (2008). Intestinal absorption mechanisms of prenylated flavonoids present in the heat-processed Epimedium koreanum Nakai (Yin Yanghuo). Pharm Res, 25:2190–2199.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Inkyo M, Yumoto R, Nagai J, Takano M, Nagata S. (2012). Nanoparticulation of probucol, a poorly water-soluble drug, using a novel wet-milling process to improve in vitro dissolution and in vivo oral absorption. Drug Dev Ind Pharm, 38:1015–1023.
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun J, Zhang T, Liu H, He F, He Z. (2012). Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems. Drug Dev Ind Pharm, 37:1225–1230.
   Web of Science ®Google Scholar
• Collnot EM, Baldes C, Wempe MF, Hyatt J, Navarro L, Edgar KJ et al. (2006). Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers. J Control Release, 111:35–40.
   PubMed Web of Science ®Google Scholar
• Christiansen A, Backensfeld T, Denner K et al. (2008). Effects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro. Eur J Pharm Biopharm, 69:158–166.
   PubMedGoogle Scholar
• Michael FW, Charles W, James LL et al. (2009). Inhibiting efflux with novel non-ionic surfactants: rational design based on vitamin E TPGS. Int J Pharm, 370:93–102.
   PubMedGoogle Scholar
• Hanke U, May K, Rozehnal V, Nagel S, Siegmund W, Weitschies W. (2010). Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2). Eur J Pharm Biopharm, 76:260–268.
   PubMed Web of Science ®Google Scholar
• Bogman K, Zysset Y, Degen L, Hopfgartner G, Gutmann H, Alsenz J et al. (2005). P-glycoprotein and surfactants: effect on intestinal talinolol absorption. Clin Pharmacol Ther, 77:24–32.
   PubMed Web of Science ®Google Scholar
• Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by D-α-to-copheryl polyethylene glycol 1000 succinate (TPGS).Pharm. Res 1999;16:1550–1556.
   Google Scholar
• Rege BD, Kao JP, Polli JE. (2002). Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci, 16:237–246.
   PubMed Web of Science ®Google Scholar
• Zhang ZP, Lee SH, Feng SS. (2007). Folate-decorated poly(lactide-co-glycolide) evitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials, 28:1889–1899.
   PubMed Web of Science ®Google Scholar
• Wu Z, Guo D, Deng L, Zhang Y, Yang Q, Chen J. (2011). Preparation and evaluation of a self-emulsifying drug delivery system of etoposide-phospholipid complex. Drug Dev Ind Pharm, 37:103–112.
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhang Y, Yang Z, Tang X. (2009). Formulation of an intravenous emulsion loaded with a clarithromycin-phospholipid complex and its pharmacokinetics in rats. Int J Pharm, 366:160–169.
   PubMed Web of Science ®Google Scholar
• Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. (2007). Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm, 330:155–163.
   PubMed Web of Science ®Google Scholar
• Gao ZG, Fain HD, Rapoport N. (2005). Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J Control Release, 102:203–222.
   PubMed Web of Science ®Google Scholar
• Goole J, Lindley DJ, Roth W, Carl SM, Amighi K, Kauffmann JM et al. (2010). The effects of excipients on transporter mediated absorption. Int J Pharm, 393:17–31.
   PubMed Web of Science ®Google Scholar
• Mu L, Elbayoumi TA, Torchilin VP. (2005). Mixed micelles made of poly(ethylene glycol)–phosphatidylethanolamine conjugate and d-α-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. J Control Rel, 306: 142–149.
   Google Scholar
• Jia DS, Jia XB, Zhao JL et al. (2010). Preparation of baohuoside I by enzymolysis of icariin with cellulase. Chinese Traditional and Herbal Drugs, 41: 888–892.
   Google Scholar
• Jin X, Zhang ZH, Sun E, Tan XB, Zhu FX, Li SL et al. (2012). Preparation of icariside II-phospholipid complex and its absorption across Caco-2 cell monolayers. Pharmazie, 67:293–298.
   PubMed Web of Science ®Google Scholar
• Grant DJW, Higuchi T. Solutility behavior of organic compounds. New York, USA: John Wiley & Sons; 1990.
   Google Scholar
• Hu M, Li Y, Davitt CM et al. (1999). Transport and metabolic character-ization of Caco-2 cells expressing CYP3A4 and CYP3A4 plusoxidoreductase. Pharm. Res, 16: 1352–1359.
   PubMed Web of Science ®Google Scholar
• Maestrelli F, Cirri M, Mennini N, Bragagni M, Zerrouk N, Mura P. (2012). Influence of cross-linking agent type and chitosan content on the performance opectinate-chitosan beads aimed for colon-specific drug delivery. Drug Dev Ind Pharm, 38: 1142–1151.
   PubMed Web of Science ®Google Scholar
• Hu M, Chen J, Lin H. (2003). Metabolism of flavonoids via enteric recycling: mechanistic studies of disposition of apigenin in the Caco-2 cell culture model. J Pharmacol Exp Ther, 307:314–321.
   PubMed Web of Science ®Google Scholar
• Bandivadeka MM, Pancholi SS, Kaul-Ghanekar R, Choudhari A, Koppikar S.. (2012). Self-microemulsifying smaller molecular volume oil (Capmul MCM)using non-ionic surfactants: a deliverysystem for poorly water-soluble drug. Drug Dev Ind Pharm, 38:883–892.
   PubMed Web of Science ®Google Scholar
• Merzlikine A, Rotter C, Rago B, Poe J, Christoffersen C, Thomas VH et al. (2009). Effect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats. Drug Dev Ind Pharm, 35:1082–1091.
   PubMed Web of Science ®Google Scholar
• Xiao YY, Song YM, Chen ZP et al. (2006). The preparation of silybin–phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm, 307: 77–82.
   PubMed Web of Science ®Google Scholar
• Wahlang B, Pawar YB, Bansal AK. (2011). Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm, 77:275–282.
   PubMed Web of Science ®Google Scholar
• Fischer SM, Brandl M, Fricker G. (2011). Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers. Eur J Pharm Biopharm, 79:416–422.
   PubMed Web of Science ®Google Scholar
• Collnot EM, Baldes C, Wempe MF, et al. (2007). Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity andmembrane fluidity. Mol. Pharm, 4: 465–474.
   PubMed Web of Science ®Google Scholar
• Norris DA, Puri N, Sinko PJ. (1998). The effect of physical barriers and properties on the oral absorption of particulates. Adv Drug Deliv Rev, 34:135–154.
   PubMed Web of Science ®Google Scholar
• Jung T, Kamm W, Breitenbach A, et al. (2000). Biodegradable nanoparticle for oral delivery of peptides: is there a role for polymers to affect mucosal uptake. Eur J. Pharm Biopharm, 50: 147–160.
   PubMed Web of Science ®Google Scholar
• Behrens I, Stenberg P, Artursson P, Kissel T. (2001). Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells. Pharm Res, 18:1138–1145.
   PubMed Web of Science ®Google Scholar
• Allen C, Yu Y, Eisenberg A, Maysinger D. (1999). Cellular internalization of PCL(20)-b-PEO(44) block copolymer micelles. Biochim Biophys Acta, 1421:32–38.
   PubMed Web of Science ®Google Scholar
• Luo L, Tam J, Maysinger D et al. (2002). Cellular internalization of poly(ethylene-oxide)-b-poly(epsilon-caprolactone) diblock copolymer micelles. Bioconjugate Chem, 13: 1259–1265.
   PubMed Web of Science ®Google Scholar
• Benet LZ, Izumi T, Zhang Y, Silverman JA, Wacher VJ. (1999). Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery. J Control Release, 62:25–31.
   PubMed Web of Science ®Google Scholar
• Wagner D, Spahn-Langguth H, Hanafy A et al. (2001). Intestinal drug efflux: formulation and food effects. Adv. Drug Deliv, 50: 13–31.
   PubMed Web of Science ®Google Scholar